Somatic NF1 mutational spectrum in benign neurofibromas: MRNA splice defects are common among point mutations

Human Genetics

Volumn 108, Issue 5, 2001, Pages 416-429

  Serra, E ^a   Ars, E ^a   Ravella, A ^a   Sanchez A ^a   Puig, S ^a   Rosenbaum, T ^a   Estivill, X ^a   Lazaro C ^a  

^a HOSPITAL DURAN I REYNALS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA;

ARTICLE; CHROMOSOME 17Q; CHROMOSOME ARM; CLINICAL ARTICLE; CLINICAL OBSERVATION; CONTROLLED STUDY; DISEASE COURSE; GENE INACTIVATION; GERM LINE; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; MOLECULAR DYNAMICS; NERVE SHEATH TUMOR; NEUROFIBROMA; NEUROFIBROMATOSIS; POINT MUTATION; PRIORITY JOURNAL; RNA SPLICING; SOMATIC MUTATION; SPECTRUM; TUMOR CELL; TUMOR DIFFERENTIATION;

ALLELES; BASE SEQUENCE; CHROMOSOMES, HUMAN, PAIR 17; DNA MUTATIONAL ANALYSIS; EXONS; FEMALE; FIBROBLASTS; GENETIC MARKERS; GENOTYPE; GERM-LINE MUTATION; HUMANS; LOSS OF HETEROZYGOSITY; MALE; NERVE TISSUE PROTEINS; NEUROFIBROMA; NEUROFIBROMATOSIS 1; NEUROFIBROMIN 1; PEDIGREE; POINT MUTATION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; RNA SPLICE SITES; RNA SPLICING; RNA, MESSENGER;

EID: 0035007009     PISSN: 03406717     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004390100514     Document Type: Article

References (69)

1. Rapid nonradioactive detection by PCR of pHHH202/RsaI RFLP linked to neurofibromatosis type I
2. Example of somatic mosaicism in a series of de novo neurofibromatosis type 1 cases due to a maternally derived deletion
3. Mutations affecting mRNA splicing are the most common molecular defects in patients with neurofibromatosis type 1
4. Cold shock induces the insertion of a cryptic exon in the neurofibromatosis type 1 (NF1) mRNA
5. The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins
6. Complete human NF1 cDNA sequence: Two alternatively spliced mRNAs and absence of expression in a neuroblastoma line
7. Characterization of full-length neurofibromin: Tubulin inhibits Ras GAP activity
8. Benign neurofibromas in type neurofibromatosis (NF1) show somatic deletions of the NF1 gene
9. Somatic mosaicism in a patient with neurofibromatosis type 1
10. Clonal origin of tumor cells in a plexiform neurofibroma with LOH in NF1 intron 38 and in dermal neurofibromas without LOH of the NF1 gene
11. The protein product of the neurofibromatosis type 1 gene is expressed at highest abundance in neurons, Schwann cells, and oligodendrocytes
12. A comprehensive genetic map of the human genome based on 5,264 microsatellites
13. NF1 microdeletion breakpoints are clustered at flanking repetitive sequences
14. Malignant peripheral nerve sheath tumors. A clinicopathologic study of 120 cases
15. An analysis of variation in expression of neurofibromatosis (NF) type 1 (NF1): Evidence for modifying genes
16. Toward a survey of somatic mutation of the NF1 gene in benign neurofibromas of patients with neurofibromatosis type 1
17. Effects of cholera toxin and isobutylmethylxanthine on growth of human fibroblasts
18. Minor lesion mutational spectrum of the entire NF1 gene does not explain its high mutability but points to a functional domain upstream of the GAP-related domain
19. Neurofibromatosis type 1 gene product (neurofibromin) associates with microtubules
20. Requirement of Drosophila NF1 for activation of adenylyl cyclase by PACAP38-like neuropeptides
21. A neurofibromatosis-1-regulated pathway is required for learning in Drosophila
22. An RsaI polymorphism in the transcribed region of the neurofibromatosis (NF1) gene
23. Neurofibromatosis 1: A clinical and genetic overview
24. A search for evidence of somatic mutations in the NF1 gene
25. Inactivation of the NF1 gene in human melanoma and neuroblastoma cell lines without impaired regulation of GTP-Ras
26. Neurofibromin can inhibit Ras-dependent growth by a mechanism independent of its GTPase-accelerating function
27. Loss of NF1 allele in Schwann cells but not in fibroblasts derived from an NF1-associated neurofibroma
28. Allelic loss of the NF1 gene in NF1-associated plexiform neurofibromas
29. Mutation and cancer: Statistical study of retinoblastoma
30. Novel alleles, hemizygosity and deletions at an Alu-repeat within the neurofibromatosis type 1 (NF1) gene
31. Two CA/GT repeat polymorphisms in intron 27 of the human neurofibromatosis (NF1) gene
32. Somatic deletion of the neurofibromatosis type 1 gene in a neurofibrosarcoma supports a tumour suppressor gene hypothesis
33. Genomic organization of the neurofibromatosis 1 gene (NF1)
34. Molecular studies in 20 submicroscopic neurofibromatosis type 1 gene deletions
35. Unequal meiotic crossover: A frequent cause of NF1 microdeletions
36. Selected locus and multiple panel models for radiation hybrid mapping
37. NF1 inactivation cooperates with N-ras in in vivo lymphogenesis activating Erk by a mechanism independent of its Ras-GTPase accelerating activity
38. A yeast artificial chromosome contig encompassing the type 1 neurofibromatosis gene
39. The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21
40. Characterization and significance of nine novel mutations in exon 16 of the neurofibromatosis type 1 (NF1) gene
41. Exhaustive mutation analysis of the NF1 gene allows identification of 95% of mutations and reveals a high frequency of unusual splicing defects
42. A simple salting out procedure for extracting DNA from human nucleated cells
43. Cellular differentiation and expression of matrix genes in type 1 neurofibromatosis
44. Chromosome 17 loss-of-heterozygosity studies in benign and malignant tumors in neurofibromatosis type 1
45. A genetic study of neurofibromatosis type 1 (NF1) in south-western Ontario. II. A PCR based approach to molecular and prenatal diagnosis using linkage
46. Purification and expansion of human Schwann cells in vitro
47. Genetic and cellular defects contributing to benign tumor formation in neurofibromatosis type 1
48. Identification of NF1 mutations in both alleles of a dermal neurofibroma
49. Confirmation of a double-hit model for the NF1 gene in benign neurofibromas
50. Schwan cells harbor the somatic NF1 mutation in neurofibromas: Evidence of two different schwann cell subpopulations
51. Angiogenic and invasive properties of neurofibroma Schwann cells
52. Homozygous inactivation of the NF1 gene in bone marrow cells from children with neurofibromatosis type 1 and malignant myeloid disorders
53. RNA processing and clinical variability in neurofibromatosis type I (NF1)
54. The neurofibroma in von Recklinghausen neurofibromatosis has a unicellular origin
55. Long-term follow-up of von Recklinghausen neurofibromatosis. Survival and malignant neoplasms
56. An STS-based radiation hybrid map of the human genome
57. Somatic mosaicism of a greater than 1.7-Mb deletion of genomic DNA involving the entire NF1 gene as verified by FISH: Further evidence for a contiguous gene syndrome in 17q11.2
58. Rescue of a Drosophila NF1 mutant phenotype by protein kinase A
59. Segmental neurofibromatosis is caused by somatic mutation of the neurofibromatosis type 1 (NF1) gene
60. Mutational and functional analysis of the neurofibromatosis type 1 (NF1) gene
61. Type 1 neurofibromatosis gene: Identification of a large transcript disrupted in three NF1 patients
62. Dinucleotide repeat polymorphisms at the D17S250 and D17S261 loci
63. Illegitimate splicing of the NF1 gene in healthy individuals mimics mutation-induced splicing alterations in NF1 patients
64. Somatic mosaicism for deletion of the entire NF1 gene identified by FISH
65. A simple, and method for isolation of high quality genomic DNA from animal tissues
66. The neurofibromatosis type 1 gene encodes a protein related to GAP
67. An Alu polymorphism intragenic to the neurofibromatosis type 1 gene (NF1)